$CVRX
CVRx, Inc.

2022 Q3 Form 10-Q Financial Statement

#000155837022011466 Filed on August 01, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $6.186M $5.031M $4.076M
YoY Change 82.21% 61.1% 42.52%
Cost Of Revenue $1.340M $1.201M $949.0K
YoY Change 52.97% 31.54% 9.46%
Gross Profit $4.846M $3.830M $3.127M
YoY Change 92.38% 73.3% 56.9%
Gross Profit Margin 78.34% 76.13% 76.72%
Selling, General & Admin $12.68M $12.49M $10.78M
YoY Change 56.32% 121.95% 141.64%
% of Gross Profit 261.64% 326.08% 344.64%
Research & Development $2.293M $2.355M $2.258M
YoY Change 34.96% 4.43% 29.03%
% of Gross Profit 47.32% 61.49% 72.21%
Depreciation & Amortization $127.0K $95.00K $62.00K
YoY Change 202.38% 156.76% 87.88%
% of Gross Profit 2.62% 2.48% 1.98%
Operating Expenses $14.97M $14.84M $13.04M
YoY Change 52.62% 88.33% 109.9%
Operating Profit -$10.13M -$11.01M -$9.908M
YoY Change 38.88% 94.18% 134.95%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net $328.0K -$34.00K -$57.00K
YoY Change -81.73% -99.7% -98.5%
Pretax Income -$9.798M -$11.05M -$9.965M
YoY Change 60.36% -37.66% 15.74%
Income Tax $32.00K $23.00K $26.00K
% Of Pretax Income
Net Earnings -$9.830M -$11.07M -$9.991M
YoY Change 60.28% -37.62% 15.81%
Net Earnings / Revenue -158.91% -220.06% -245.12%
Basic Earnings Per Share -$0.48 -$0.54 -$0.49
Diluted Earnings Per Share -$0.48 -$0.49 -$0.49
COMMON SHARES
Basic Shares Outstanding 20.58M 20.51M 20.45M
Diluted Shares Outstanding 20.58M 20.45M 20.45M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $110.0M $121.3M $131.2M
YoY Change -35.65% 157.48% 143.05%
Cash & Equivalents $110.0M $121.3M $131.2M
Short-Term Investments
Other Short-Term Assets $3.066M $1.155M $2.090M
YoY Change 4.89% -31.41% 97.36%
Inventory $6.064M $5.834M $5.261M
Prepaid Expenses
Receivables $5.297M $3.601M $3.673M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $124.4M $131.9M $142.2M
YoY Change -31.15% 143.35% 137.91%
LONG-TERM ASSETS
Property, Plant & Equipment $1.747M $1.610M $1.656M
YoY Change 85.26% 96.34% 246.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $26.00K $26.00K $26.00K
YoY Change -61.19% 0.0% 0.0%
Total Long-Term Assets $2.164M $2.101M $2.204M
YoY Change 114.26% 148.35% 337.3%
TOTAL ASSETS
Total Short-Term Assets $124.4M $131.9M $142.2M
Total Long-Term Assets $2.164M $2.101M $2.204M
Total Assets $126.6M $134.0M $144.4M
YoY Change -30.34% 143.43% 139.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.276M $608.0K $1.607M
YoY Change 135.86% -31.53% 89.73%
Accrued Expenses $6.120M $5.301M $4.985M
YoY Change 22.97% 40.54% 43.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.396M $5.909M $6.592M
YoY Change -16.44% -76.41% -44.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $761.0K $732.0K $706.0K
YoY Change -19.13% -17.19% -14.42%
Total Long-Term Liabilities $761.0K $732.0K $706.0K
YoY Change -95.55% -96.14% -96.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.396M $5.909M $6.592M
Total Long-Term Liabilities $761.0K $732.0K $706.0K
Total Liabilities $8.332M $6.891M $7.602M
YoY Change -67.88% -84.34% -76.32%
SHAREHOLDERS EQUITY
Retained Earnings -$425.6M -$415.8M -$404.7M
YoY Change 10.79% 9.99%
Common Stock $544.1M $543.2M $541.8M
YoY Change 0.73% 815.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $118.2M $127.1M $136.8M
YoY Change
Total Liabilities & Shareholders Equity $126.6M $134.0M $144.4M
YoY Change -30.34% 143.43% 139.58%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$9.830M -$11.07M -$9.991M
YoY Change 60.28% -37.62% 15.81%
Depreciation, Depletion And Amortization $127.0K $95.00K $62.00K
YoY Change 202.38% 156.76% 87.88%
Cash From Operating Activities -$11.10M -$10.10M -$10.64M
YoY Change 20.41% 56.19% 111.27%
INVESTING ACTIVITIES
Capital Expenditures -$264.0K -$49.00K $293.0K
YoY Change 60.0% -87.07% 190.1%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$264.0K -$49.00K -$293.0K
YoY Change 60.0% -87.07% 190.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.000K 321.0K 48.00K
YoY Change -99.99% 2300.0%
NET CHANGE
Cash From Operating Activities -11.10M -10.10M -10.64M
Cash From Investing Activities -264.0K -49.00K -293.0K
Cash From Financing Activities 7.000K 321.0K 48.00K
Net Change In Cash -11.35M -9.824M -10.90M
YoY Change -109.17% 43.56% 111.92%
FREE CASH FLOW
Cash From Operating Activities -$11.10M -$10.10M -$10.64M
Capital Expenditures -$264.0K -$49.00K $293.0K
Free Cash Flow -$10.83M -$10.05M -$10.94M
YoY Change 19.69% 65.11% 112.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
127146000
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-48.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-72.58
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20453341
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
366066
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20453341
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1983744
dei Entity Address Address Line1
EntityAddressAddressLine1
9201 West Broadway Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 650
dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55445
dei City Area Code
CityAreaCode
763
dei Local Phone Number
LocalPhoneNumber
416-2840
dei Security12b Title
Security12bTitle
Common stock,
dei Trading Symbol
TradingSymbol
CVRX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
363397
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20453341
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
366066
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20453341
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
363397
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-48.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-72.58
dei Entity Central Index Key
EntityCentralIndexKey
0001235912
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2021Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2022Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20576149
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20399337
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.025
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40545
dei Entity Registrant Name
EntityRegistrantName
CVRx, Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20576202
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121346000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
142072000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3601000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20399337
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
134037000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152548000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
206000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2560000
CY2022Q2 us-gaap Inventory Net
InventoryNet
5834000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3880000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1155000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2585000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
131936000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
151097000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1610000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1425000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
465000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26000
CY2022Q2 us-gaap Assets
Assets
134037000
CY2021Q4 us-gaap Assets
Assets
152548000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
608000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
510000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5301000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5398000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5909000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5908000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
250000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
732000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
681000
CY2022Q2 us-gaap Liabilities
Liabilities
6891000
CY2021Q4 us-gaap Liabilities
Liabilities
6589000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20576149
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
204000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
542967000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
540707000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-415816000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-394754000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-211000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-198000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
127146000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
145959000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5031000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3123000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9107000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5983000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
1201000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
913000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-48.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-72.58
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20505228
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
366066
us-gaap Cost Of Revenue
CostOfRevenue
2150000
us-gaap Cost Of Revenue
CostOfRevenue
1780000
CY2022Q2 us-gaap Gross Profit
GrossProfit
3830000
CY2021Q2 us-gaap Gross Profit
GrossProfit
2210000
us-gaap Gross Profit
GrossProfit
6957000
us-gaap Gross Profit
GrossProfit
4203000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2355000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2255000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4613000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4005000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12489000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5627000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23266000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10087000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
14844000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
7882000
us-gaap Operating Expenses
OperatingExpenses
27879000
us-gaap Operating Expenses
OperatingExpenses
14092000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11014000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5672000
us-gaap Operating Income Loss
OperatingIncomeLoss
-20922000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9889000
CY2021Q2 us-gaap Interest Expense
InterestExpense
608000
us-gaap Interest Expense
InterestExpense
1209000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-34000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11442000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-91000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15234000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11048000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17722000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21013000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26332000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11071000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17748000
us-gaap Net Income Loss
NetIncomeLoss
-21062000
us-gaap Net Income Loss
NetIncomeLoss
-26375000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-7000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-13000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-5000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11078000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17749000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21075000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26380000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1080000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
98000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
295000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20479427
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
405000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
363397
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
136803000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
295000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1100000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11071000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-13000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1421000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20726000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11984000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-301806000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
624000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17748000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-318931000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
145959000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
74000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
295000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1893000
us-gaap Net Income Loss
NetIncomeLoss
-21062000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
127146000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-293238000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
685000
us-gaap Net Income Loss
NetIncomeLoss
-26375000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-318931000
us-gaap Profit Loss
ProfitLoss
-21062000
us-gaap Profit Loss
ProfitLoss
-26375000
us-gaap Share Based Compensation
ShareBasedCompensation
1893000
us-gaap Share Based Compensation
ShareBasedCompensation
685000
us-gaap Depreciation
Depreciation
157000
us-gaap Depreciation
Depreciation
70000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
137000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
15140000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1041000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
963000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1954000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-181000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-252000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
298000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20740000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11502000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
342000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
480000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-342000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-480000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
74000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
369000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142072000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59112000
CY2022Q2 us-gaap Inventory Net
InventoryNet
5834000
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
753000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3880000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121346000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47128000
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Interest Paid Net
InterestPaidNet
1011000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of estimates</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.</p>
CY2022Q2 cvrx Accrued Liabilities Customer Rebate Current
AccruedLiabilitiesCustomerRebateCurrent
272000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
482000
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2455000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1593000
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2626000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1805000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
624000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1893000
CY2022Q2 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
878000
CY2021Q4 cvrx Accrued Paid Time Off
AccruedPaidTimeOff
699000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3635000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3293000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2025000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1868000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1610000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1425000
CY2022Q2 us-gaap Depreciation
Depreciation
95000
CY2021Q2 us-gaap Depreciation
Depreciation
37000
us-gaap Depreciation
Depreciation
157000
us-gaap Depreciation
Depreciation
70000
CY2022Q2 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
1788000
CY2021Q4 cvrx Clinical Trial And Other Professional Fees
ClinicalTrialAndOtherProfessionalFees
1607000
CY2022Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1610000
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2028000
CY2021Q4 cvrx Accrued Liabilities Customer Rebate Current
AccruedLiabilitiesCustomerRebateCurrent
380000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
212000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
541000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
684000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5301000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5398000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
685000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
26000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
624000
CY2021Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2022Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
465000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
212000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
250000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
462000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
115000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
234000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
139000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
488000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
462000
CY2022Q2 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P2Y1M6D
CY2022Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.050
us-gaap Operating Lease Payments
OperatingLeasePayments
600000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3452080
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.18
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4095000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
685000
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
8700000
CY2022Q2 us-gaap Preferred Stock Convertible Conversion Ratio
PreferredStockConvertibleConversionRatio
39.548
CY2021Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
11929584
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2749441
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.93
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1062318
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
240548
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.26
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
119131
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.62
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1417978
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.50
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3435000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1893000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-48.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11071000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17748000
us-gaap Net Income Loss
NetIncomeLoss
-21062000
us-gaap Net Income Loss
NetIncomeLoss
-26375000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20505228
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
366066
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20479427
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
363397
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-72.58
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4168211
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14692032
CY2022Q2 us-gaap Contractual Obligation
ContractualObligation
0
CY2021Q4 us-gaap Contractual Obligation
ContractualObligation
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5031000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3123000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9107000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5983000

Files In Submission

Name View Source Status
0001558370-22-011466-index-headers.html Edgar Link pending
0001558370-22-011466-index.html Edgar Link pending
0001558370-22-011466.txt Edgar Link pending
0001558370-22-011466-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20220630.xsd Edgar Link pending
tmb-20220630x10q.htm Edgar Link pending
tmb-20220630x10q_htm.xml Edgar Link completed
tmb-20220630xex31d1.htm Edgar Link pending
tmb-20220630xex31d2.htm Edgar Link pending
tmb-20220630xex32d1.htm Edgar Link pending
tmb-20220630xex32d2.htm Edgar Link pending
tmb-20220630_cal.xml Edgar Link unprocessable
tmb-20220630_def.xml Edgar Link unprocessable
tmb-20220630_lab.xml Edgar Link unprocessable
tmb-20220630_pre.xml Edgar Link unprocessable